Tokyo Tape
Sign in
← GNI Group

Half-year report · HY

2160.TEDINET S100YX24
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥11.9bn2026-01-01 → 2026-06-30Cons.Revenue IFRS
Revenue¥26.8bn2025-01-01 → 2025-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥12.3bn2025-01-01 → 2025-06-30Cons.Revenue IFRS
Operating income¥534m2026-01-01 → 2026-06-30Cons.Operating profit loss IFRS
Operating income−¥1.2bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Profit before tax−¥87m2026-01-01 → 2026-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥4.6bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥1.4bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥2.0bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥4.2bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥915m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥588m2026-01-01 → 2026-06-30Cons.Profit loss IFRS
Net income−¥7.2bn2025-01-01 → 2025-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥2.3bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Total assets¥81.8bnat 2026-06-30Cons.Assets IFRS
Total assets¥83.8bnat 2025-12-31Cons.Assets IFRS
Total assets¥67.7bnat 2025-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥15.3bnat 2026-06-30Cons.Liabilities IFRS
Total liabilities¥31.9bnat 2025-12-31Cons.Liabilities IFRS
Net assets / equity¥66.5bnat 2026-06-30Cons.Equity IFRS
Net assets / equity¥51.8bnat 2025-12-31Cons.Equity IFRS
Net assets / equity¥38.3bnat 2025-06-30Cons.Equity IFRS
Net assets / equity¥39.7bnat 2024-12-31vCons.Equity IFRS
Equity (owners)¥40.4bnat 2026-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥50.3bnat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥35.3bnat 2025-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥17.2bnat 2026-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.1bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.5bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.1bnat 2024-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow−¥1.6bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.4bn2025-01-01 → 2025-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥931m2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥2.5bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥536m2025-01-01 → 2025-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥632m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥191m2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥13.7bn2025-01-01 → 2025-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥1.4bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-35.662026-01-01 → 2026-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-80.92025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-18.192025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-35.662026-01-01 → 2026-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-80.92025-01-01 → 2025-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-18.192025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.5%at 2026-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio60.1%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.1%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Medical Devicereportable segmentrevenue2026-01-01 → 2026-06-30¥3.0bn
Medical Devicereportable segmentrevenue external2026-01-01 → 2026-06-30¥3.0bn
Medical Devicereportable segmentsegment profit2026-01-01 → 2026-06-30−¥2.2bn
Pharmaceuticalreportable segmentrevenue2026-01-01 → 2026-06-30¥8.9bn
Pharmaceuticalreportable segmentrevenue external2026-01-01 → 2026-06-30¥8.9bn
Pharmaceuticalreportable segmentsegment profit2026-01-01 → 2026-06-30¥2.7bn
—segment totalrevenue2026-01-01 → 2026-06-30¥11.9bn
—segment totalrevenue external2026-01-01 → 2026-06-30¥11.9bn
—segment totalsegment profit2026-01-01 → 2026-06-30¥534m
Medical Devicereportable segmentrevenue2025-01-01 → 2025-06-30¥4.1bn
Medical Devicereportable segmentrevenue external2025-01-01 → 2025-06-30¥4.1bn
Medical Devicereportable segmentsegment profit2025-01-01 → 2025-06-30¥502m
Pharmaceuticalreportable segmentrevenue2025-01-01 → 2025-06-30¥8.2bn
Pharmaceuticalreportable segmentrevenue external2025-01-01 → 2025-06-30¥8.2bn
Pharmaceuticalreportable segmentsegment profit2025-01-01 → 2025-06-30−¥1.7bn
—segment totalrevenue2025-01-01 → 2025-06-30¥12.3bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥12.3bn
—segment totalsegment profit2025-01-01 → 2025-06-30−¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 720
ItemContextValueUnit
Other current liabilities cl IFRSPrior1YearInstant2688000000JPY
Other current liabilities cl IFRSInterimInstant3850000000JPY
Total current liabilities IFRSPrior1YearInstant9594000000JPY
Total current liabilities IFRSInterimInstant10200000000JPY
Liabilities IFRSPrior1YearInstant31948000000JPY
Liabilities IFRSInterimInstant15263000000JPY
Share capital IFRSPrior1YearInstant19676000000JPY
Share capital IFRSInterimInstant19786000000JPY
Capital surplus IFRSPrior1YearInstant15773000000JPY
Capital surplus IFRSInterimInstant4270000000JPY
Treasury shares IFRSPrior1YearInstant-15000000JPY
Treasury shares IFRSInterimInstant-15000000JPY
Retained earnings IFRSPrior1YearInstant5644000000JPY
Retained earnings IFRSInterimInstant3656000000JPY
Other components of equity IFRSPrior1YearInstant9240000000JPY
Other components of equity IFRSInterimInstant12744000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant50320000000JPY
Equity attributable to owners of parent IFRSInterimInstant40441000000JPY
Non controlling interests IFRSPrior1YearInstant1522000000JPY
Non controlling interests IFRSInterimInstant26055000000JPY
Equity IFRSPrior1YearInstant51842000000JPY
Equity IFRSInterimInstant66497000000JPY
Liabilities and equity IFRSPrior1YearInstant83791000000JPY
Liabilities and equity IFRSInterimInstant81760000000JPY
Revenue IFRSPrior1InterimDuration12252000000JPY
Revenue IFRSInterimDuration11937000000JPY
Cost of sales IFRSPrior1InterimDuration3418000000JPY
Cost of sales IFRSInterimDuration3307000000JPY
Gross profit IFRSPrior1InterimDuration8833000000JPY
Gross profit IFRSInterimDuration8630000000JPY
Selling general and administrative expenses IFRSPrior1InterimDuration7995000000JPY
Selling general and administrative expenses IFRSInterimDuration11420000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1InterimDuration1596000000JPY
Research and development expenditure recognized as expense during period IFRSInterimDuration2124000000JPY
Other income IFRSPrior1InterimDuration322000000JPY
Other income IFRSInterimDuration6724000000JPY
Other expenses IFRSPrior1InterimDuration743000000JPY
Other expenses IFRSInterimDuration1275000000JPY
Operating profit loss IFRSPrior1InterimDuration-1179000000JPY
Operating profit loss IFRSInterimDuration534000000JPY
Finance income IFRSPrior1InterimDuration539000000JPY
Finance income IFRSInterimDuration252000000JPY
Finance costs IFRSPrior1InterimDuration794000000JPY
Finance costs IFRSInterimDuration864000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1InterimDuration1000000JPY
Share of profit loss of investments accounted for using equity method IFRSInterimDuration-10000000JPY
Profit loss before tax IFRSPrior1InterimDuration-1433000000JPY
Profit loss before tax IFRSInterimDuration-87000000JPY
Income tax expense IFRSPrior1InterimDuration908000000JPY
Income tax expense IFRSInterimDuration500000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass rounding
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass